|
Jared
Wadman
Update
4-20-04
>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>
Hi Marjo,
This is Jared
Wadman. How are you doing? A lot has been going on here lately.
The biggest news is that I am no longer on the treatment. I stopped
taking pills in January (with the doctor's approval, of course)
I feel great. I'm going to a local community college. I'm in my
third term and am going into the culinary arts school there in
the fall.
The main reason
that I am emailing you is, since I have beaten this disease, we
want to celebrate. We want Stan and Barbara Burzynski to fly up
here, and you and Steve and just about everybody else we've encountered
over the past 10 years (yeah, 10 years!) so anyway, I dont have
that many email addresses, and I was hoping to get some from you.
The party
would be in august (around the 15th, my 20th birthday) I hope
that gives you enough time to plan things out. If you can't come,
thats ok. I'ill understand.
I'll talk
to you later. Thanks
>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>
My name is
Ted Wadman, my wife's name is Sandy, and the children in the photograph
are our boys. Jared is now 14 years old, Cameron is 11, and Lucas
is 7. Cameron has cerebral palsy and must be dressed, fed, and
cared for completely. But as the picture indicates, overall, he
is a very joyful boy
and he loves music. Lucas is a talented
and gifted reader and generally a dynamo. At about 3 minutes old,
it was obvious that he was much smarter than his parents. Jared,
too, is a bright, talented, and cooperative kid. He helps out
a lot with the demands at home. He is a great cook, with gourmet
tastes.
Jared has
been on Dr. Burzynskis antineoplaston therapy for the last
3.5 years. At the age of 7, he was diagnosed with a low-grade
astrocytoma in his hypothalamus. A surgical biopsy was performed
by Dr. Michael Edwards, who was at the University of California
at San Francisco. We live in Oregon but chose to go to San Francisco
for the biopsy surgery. Jared had chemotherapy after surgery.
His chemotherapy consisted of vincristine, and CCNU. He was given
an experimental drug called 6TG (thioguanine), which was supposed
to cross the blood-brain barrier. This chemotherapy was all part
of an FDA-approved clinical trial conducted by MD Anderson Cancer
Center. We never found out about the results of that trial.
Jareds
tumor was stable throughout the six cycles of chemotherapy. All
the drugs except vincristine were given orally. He vomited during
the first couple cycles until we obtained Zofran. It was only
available in injectable form then, but we gave it to him orally
and it stopped the nausea. By the sixth cycle, Jareds blood
counts dipped dangerously low. In the realm of chemotherapy, however,
he handled it well.
Then the waiting
began. Jared had MRIs every 3 months. He had no symptoms from
the tumor except the original problem (precocious puberty), which
is easy to treat. His tumor was stable until March of 1995 when
Jared was 10 years old. At that time, everyone agreed the tumor
had begun to grow. Jared's doctors at UCSF recommended stronger
chemotherapy or radiation. The chemotherapy would be carboplatin
and vincristine. Jared would lose his hair, suffer liver damage,
nerve damage, kidney damage, bone marrow damage, and more. At
the appointment with his oncologist in Portland, we spent an hour
discussing the side effects and no time at all discussing the
benefits of this therapy. All this for a child who was otherwise
completely healthy. The only indication that the tumor was growing
was the MRI.
Sandy had
read about Dr. Burzynski in the book Choices in Healing by Michael
Lerner. We decided to take Jared to the clinic to see if we might
want to try this approach first. The prospect of a nontoxic treatment
for our otherwise completely healthy child was too good to pass
up. Jareds tumor was slow growing, and we felt time was
on our side. We did feel pressure to start treatment from our
oncologists. They told us that "the bigger it gets the harder
it is to treat." We chose to go to Houston to study and explore
antineoplastons.
We hung out
at the clinic for a week, talked to other patients, had an appointment
with Dr. Burzynski, and talked to the doctors and our oncologists.
We talked with the Michaels, whose child had the exact same tumor
in the exact same place as Jared (see Pauls story on this
website). Surprisingly, the oncologists at UCSF were very negative
about Jared starting antineoplaston therapy, even though they
themselves were proposing "unproven" treatments. Our
oncologist in Portland had only one comment: "The toxicity
of the chemotherapy we are proposing is definitely a consideration."
At the end
of the week at the Burzynski Clinic, we decided to put Jared on
antineoplastons. Two weeks later (after returning to our home
in Oregon), Jared started vomiting and stumbling around. The doctors
at the Clinic said the uric acid levels in his blood must be high.
We took Jared off antineoplaston treatment, and he had a blood
test. His uric acid level was three times the normal level. The
doctors said that this was an indication the tumor was breaking
down. We gave Jared a glucose infusion, and his uric acid decreased.
We then resumed antineoplaston treatment. Jared has been on allopurinol
ever since to control the uric acid levels in his blood. The uric
acid elevation has been the only side effect Jared has had from
antineoplastons.
It took about
9 months for everyone (UCSF, Dr. Burzynski, and the radiologist
in Corvallis) to agree that the tumor was shrinking. Jared is
in partial remission, and his tumor continues to shrink a little
with each MRI. We will keep Jared on antineoplaston therapy until
the tumor is gone.
Between treatments,
Jared leads a relatively normal life. He is strong, healthy, and
happy. He made the honor roll last year, plays piano at church,
and is a great big brother to Cameron and Lucas.
The logic
we used to choose antineoplaston therapy for Jared was different
than most patients who arrive at the Burzynski Clinic. Most have
already failed chemotherapy and radiation therapy. Most are in
very poor health from the ravages of chemotherapy, radiation,
and long-term use of steroids. Most arrive in a desperate situation.
Luckily, we were not at the point of desperation. We chose antineoplastons
because we had time to seek out, learn about, and try this nontoxic
treatment first.
We are active
members of the Burzynski Patient Organization. Our personal goal
is to see that everyone with a malignant brain tumor has access
to antineoplaston therapy as a first-line treatment through any
hospital in America. The FDA should have approved antineoplastons
at least 5 years ago based on results in patients with brain tumors.
Instead, the FDA has met Dr. Burzynski with ridiculous resistance,
delays, and power playing that has cost many lives. No child should
be given chemotherapy or be subjected to radiation as therapy
for a malignant brain tumor without first seeing if antineoplaston
therapy will work for them. We are working very hard to ensure
that all children with malignant brain tumors get the same chance
that Jared has had.
Ted Wadman
This patient has requested to be contacted through Burzynski Patient Group. <maryjo@siegel.net>
|